Network Member Profile
|

|
A/PROF VICKI CLIFTON
Department:
School of Paediatrics and Reproductive Health
Organisation:
University of Adelaide
Address:
Medical School North, Level 6, Frome Rd, Adelaide SA 5005
Telephone: 08 8303 8321 Facsimile: 08
8303 4099
Email: vicki.clifton@adelaide.edu.au
|
Current Field of Study
Australian Collaborators
- Prof Euan Wallace, Obstetrics and Gynaecology, Monash Medical Centre, Clayton,
Victoria to examine the effects of glucocorticoids on placental blood flow
in vitro (1 paper published)
- Dr Tony Perkins University of Queensland we are examining the activity of
anti-oxidant enzymes in placentae collected from asthmatic pregnancies (2
papers published).
- Prof David Walker, Dept Physiology, Monash University examining placental
glucocorticoid pathways in spiny mouse.
International Collaborators
- Professor John Challis and Dr Alison Holloway, Department of Physiology,
University of Toronto Canada examining urocortin actions in the sheep fetal
pituitary (abstract and 1 publication).
- Professor Terry Mayhew, University of Nottingham UK to examine the placental
stereology of asthmatic placentae (2 abstracts and a paper in submission).
- Prof Stephen Mathews, Department of Physiology, University of Toronto Canada
and Dr William Gibb University of Ottawa examining MDR gene in asthmatic placentae.
- A/Professor Isabella Caniggia and Prof Igor Jurisica of Samuel Lunenfeld
Research Institute, Toronto, Canada examining gene expression in asthmatic
placentae using microarray analysis and bioinformatics ( international grant
application, 2 abstracts).
- Prof Nicholas Illsley and A.Prof Stacy Zamudio of New Jersey Medical Centre,
NY, USA examining 11beta HSD 2 activity in placentae of high altitude pregnancies
(1 abstract).
- Prof Martin Post, Sick Childrens Hospital, Toronto Canada examining GR receptor
in placentae of asthmatic pregnancies.
- Dr Jeff Keelan, Liggins Institute, Auckland NZ examining inflammatory pathways
in fetal membranes of asthmatic pregnancies.
- Prof Pawel Zarzycki, University of Kozsalin, Poland, examining fetal cord
blood steroid profiles (1 paper published, 1 paper submitted).
Facilities
Biomolecular Research Facility - microarray - proteomic technology-MALDI-TOF,
electron microscope, mass spectrometry, gas chromatography, DNA sequencing,
protein sequencing
Lab Members
|
|
A/Prof Vicki Clifton
|
Head of the Lab
|
| Ms Naomi Scott |
PhD Student |
| Dr Michael Stark |
PhD Student |
| Mr Jorge Tolosa |
PhD Student |
| Mr John Schjenken |
PhD Student |
| Ms Olivia Wynne |
PhD Student |
| Ms Penelope McLernon |
PhD Student |
| Ms Nicki Hodyl |
Research assistant |
| Ms Patricia Engel |
Masters student |
| Dr Rachel Burgess |
Postdoctoral artist-in-residence |
| Ms Erin Green |
Honours Student |
Grant Income
|
|
Description
|
CIs
|
Type of Grant
|
Year
|
Income p.a.
|
| The effect of asthma during pregnancy on placental function
and fetal development" |
Dr VL Clifton |
NHMRC Career Development Grant: RD Wright Fellowship
Grant ID: 300786
|
2004-2008 |
89,000 |
| Managing asthma in pregnancy: the MAP study |
CIA: Prof P Gibson, CIB: Prof VL Clifton, CIC: Dr K McCaffery,
CID: Professor M J Hensley CIE: Prof W B Giles |
National Health and Medical Research Council Grant ID 455592 |
2006-2010 |
200,000 |
| The effect of maternal asthma and its treatment on placental
p38 MAP Kinase activity |
VL Clifton |
Asthma Foundation of NSW |
2007 |
50,000 |
Recent Publications
VC11. McLean M, Bowman M, Clifton V, Smith R, Grossman A. (2000) Expression
of the heme oxygenase-carbon monoxide signalling system in human placenta. J
Clin Endocrinol Metab 85(6):2345 -2349. Impact Factor=5.78, Citations=26
VC12. Clifton VL, Qing G, Murphy VE, Schwartz J, Madsen G, Smith R. (2000)
Localisation and characterization of urocortin during human pregnancy. Placenta
21(8):782-788. Impact factor=2.68. Citations=24
VC13. Gu Q, Clifton VL, Schwartz J, Madsen G, Sha J, Smith R 2001 Characterization
of urocortin in human pregnancy. Chin Med J (Engl) 114:618-22
VC14. Clifton VL, Giles WB, Smith R, Bisits AT, Hempenstall P, Kessell CG,
Gibson PG. 2001 Alterations of placental vascular function in asthmatic pregnancies.
Am J Respir Crit Care Med 164:546-53 Impact factor=8.12, Citations=19
VC15. Holloway AC, Howe DC, Chan G, Clifton VL, Smith R, Challis JR 2002 Urocortin:
a mechanism for the sustained activation of the HPA axis in the late-gestation
ovine fetus? Am J Physiol Endocrinol Metab 283:E165-71 Impact factor=4.43, Citations=5
VC16. Clifton VL, Wallace EM, Smith R 2002 Short-term effects of glucocorticoids
in the human fetal-placental circulation in vitro. J Clin Endocrinol Metab 87:2838-42
Impact factor=5.78, Citations=7
VC17. O'Dwyer DT, Clifton V, Hall A, Smith R, Robinson PJ, Crock PA 2002 Pituitary
autoantibodies in lymphocytic hypophysitis target both gamma- and alpha-Enolase
- a link with pregnancy? Arch Physiol Biochem 110:94-8.
VC18. Murphy VE, Zakar T, Smith R, Giles WB, Gibson PG, Clifton VL 2002 Reduced
11beta-hydroxysteroid dehydrogenase type 2 activity is associated with decreased
birth weight centile in pregnancies complicated by asthma. J Clin Endocrinol
Metab 87:1660-8
Impact factor=5.78, Citations=22
VC19. Clifton VL, Crompton R, Smith R, Wright IM 2002 Microvascular effects
of CRH in human skin vary in relation to gender. J Clin Endocrinol Metab 87:267-70
Impact factor=5.78, Citations=13
VC20. Murphy VE, Gibson PG, Giles WB, Smith, R. and Clifton VL. 2003 Maternal
asthma is associated with reduced female fetal growth. Am J Respir Crit Care
Med 168:1317-23
Impact factor=8.12, Citations=27
VC21. Murphy VE, Clifton VL 2003 Alterations in human placental 11beta-hydroxysteroid
dehydrogenase type 1 and 2 with gestational age and labour. Placenta 24:739-44
Impact factor=2.68. Citations=14
VC22. Crompton R, Clifton VL, Bisits AT, Read MA, Smith R, Wright IM 2003 Corticotropin-releasing
hormone causes vasodilation in human skin via mast cell-dependent pathways.
J Clin Endocrinol Metab 88:5427-32
Impact factor=5.78, Citations16
VC23. Johnson RF, Mitchell CM, Clifton V, Zakar T 2004 Regulation of 15-hydroxyprostaglandin
dehydrogenase (PGDH) gene activity, messenger ribonucleic acid processing, and
protein abundance in the human chorion in late gestation and labor. J Clin Endocrinol
Metab 89:5639-48. Impact factor=5.78 Citations=3.
VC24. Murphy VE, Johnson RF, Wang YC, Akinsanya K, Gibson PG, Smith R, Clifton
VL 2005 The effect of maternal asthma on placental and cord blood protein profiles.
J Soc Gynecol Investig 12:349-55. Impact factor=2.29, Citations=5
VC25. Clifton VL, Crompton R, Read MA, Gibson PG, Smith R, Wright IM 2005 Microvascular
effects of corticotropin-releasing hormone in human skin vary in relation to
estrogen concentration during the menstrual cycle. J Endocrinol 186:69-76. Impact
factor=3.31. Citations=2
VC26. Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV
2005 Increased biological oxidation and reduced anti-oxidant enzyme activity
in pre-eclamptic placentae. Placenta 26:53-8. Impact Factor 2.68. Citations
=0
VC27. Murphy VE, Gibson PG, Talbot PI, Kessell CG, Clifton VL 2005 Asthma self-management
skills and the use of asthma education during pregnancy. Eur Respir J 26:435-41.
Impact Factor 3.09. Citations =4
VC28. Osei-Kumah A, Ammit AJ, Smith R, Ge Q, Clifton VL 2005 Inflammatory Mediator
Release in Normal Bronchial Smooth Muscle Cells is Altered by Pregnant Maternal
and Fetal Plasma Independent of Asthma. Placenta Epub ahead of print Oct 21
2005. Impact factor 2.68. Citations=1
VC29. Clifton VL, Vanderlelie J, Perkins AV 2005 Increased anti-oxidant enzyme
activity and biological oxidation in placentae of pregnancies complicated by
maternal asthma. Placenta 26:773-9. Impact factor 2.68
VC30. Murphy VE, Gibson P, Talbot PI, Clifton VL 2005 Severe Asthma Exacerbations
During Pregnancy. Obstet Gynecol 106:1046-1054. Impact factor= 3.51. Citations=3
VC31. Murphy VE, Johnson RF, Wang YC Akinsanya K, Gibson PG, Smith R, Clifton
VL 2006 Proteomic study of plasma proteins in pregnant women with asthma. Respirology
11:41-8. Impact factor=0.93 Citations=1
VC32. Clifton VL, Rennie N, Murphy VE 2006 Effect of inhaled glucocorticoid
treatment on placental 11beta hydroxysteroid dehydrogenase type 2 activity and
neonatal birth weight in pregnancies complicated by asthma. Australian and New
Zealand Journal of Obstetrics and Gynaecology (in press). Citation=3 Impact
Factor =0.43
VC33. Zarzycki PK, Kulhanek KM, Smith R, Clifton VL 2006 Determination of steroids
in human plasma using temperature-dependent inclusion chromatography for metabolomic
investigations. J Chromatogr A 1104:203-8. Impact factor = 3.36
VC34. Murphy VE, Fittock R, Zarzycki P, Delahunty M, Smith R, Clifton VL 2007
Metabolism of synthetic steroids by the human placenta. Placenta 28:39-46. Impact
factor 2.68
VC35 Stark MJ, Dierkx L, Clifton VL and Wright IMR 2006 Alterations in the
maternal peripheral response in pregnancies complicated by pre-eclampsia and
the impact of fetal sex. Journal of the Society of Gynecologic Investigation
13:573-578.
VC36 Hodyl, N.A, Walker, FR., Krivanek, KN., Clifton, VL., Hodgson, DM. (2007)
Modelling prenatal bacterial infection; functional consequences of altered HPA
development. Behavioural brain research (accepted Dec 2006, in press).
Reviews
VC37. Schwartz J, Revskoy S, Redei E, Clifton V, Smith R, Cherny R 2002 Corticotrophs
and peptides. Arch Physiol Biochem 110:146-53.
VC38. Clifton VL, Murphy VE 2004 Maternal asthma as a model for examining fetal
sex-specific effects on maternal physiology and placental mechanisms that regulate
human fetal growth. Placenta 25 Suppl A:S45-52. Impact factor= 2.68
VC39. Murphy VE, Gibson PG, Smith R, Clifton VL 2005 Asthma during pregnancy:
mechanisms and treatment implications. Eur Respir J 25:731-50. Impact Factor=3.096
VC40. Clifton VL 2005 (invited review) Sexually dimorphic effects of maternal
asthma during pregnancy on placental glucocorticoid metabolism and fetal growth.
Cell Tissue Res 322:63-71.
VC41. Murphy VE, Clifton VL, Gibson PG 2006 Asthma exacerbations during pregnancy:
incidence and association with adverse pregnancy outcomes. Thorax 61:169-76.
Impact Factor=5.04
VC42. Murphy VE, Smith R, Giles WB, Clifton VL 2006 Endocrine regulation of
human fetal growth: the role of the mother, placenta and fetus. Endocr Rev 27:141-169.
Impact Factor=18.12
VC43 Clifton VL 2006 (invited review) Maternal asthma during pregnancy and
fetal outcomes: potential mechanisms and possible solutions. Curr Opin Allergy
Clin Immunol (in press accepted April 2006)
Book Chapters
VC44. Smith, R., Chan, E-C., Mesiano, S., Nicholson, R, Cheng, Y-H., Bowman,
M., Clifton, V., Madsen, G., Fitter, J.T., Giles, W., and Bisits, A. (2000)
Regulation of Parturition: The Role of CRH. (Chapter 24) Hormones and Women's
Health: The Reproductive Years. Vol 1. Harwood Academic Publishers imprint,
part of The Gordon and Breach Publishing Group.
VC45. Smith R, Mesiano S, Clifton V, Chan E-C, Zakar T, Nicholson R, Giles
W, Bisits A. The Pathway To Human Birth. Ed. Carlos Simón. Cuadernos
de Medicina Reproductiva, Editorial Médica Panamericana (peer reviewed)
2003 Volume 9, Number 2.
VC46. Smith R, Mesiano S, Nicholson R, Zakar T, Chan E-C, Bisits A, Clifton
V, Giles W. Control of the Length of Gestation - Lessons from Women. Preterm
Birth. Eds. Bennet and Thornton. Publisher: Royal College Obstetrics Gynecology.
(peer reviewed) 2004 pp13-27.
VC47. Smith R, Mesiano S, Nicholson R, Clifton V, Zakar T, Chan E-C, Bisits
A, Giles W. The Regulation of Human Parturition. In: Birth, Distress and Disease.
Eds. Michael L Power, Jay Schulkin. Publisher: Cambridge University Press, Cambridge
UK pp77-90 (peer reviewed) 2005
VC48. Murphy, V.E., Smith, R., Giles, W.B and Clifton V.L. 2006 The role of
the mother, placenta, and fetus in the control of fetal growth during human
pregnancy IN "Perinatal Programming: Early Life Determinants of Adult Health
and Disease", eds D Hodgson and C. Coe. p 3-17 Taylor and Francis, UK,
|